Valuation : Almirall, S.A.

Market Cap 2.26B 2.63B 2.12B 1.94B 3.65B 251B 3.66B 25.19B 9.83B 127B 9.87B 9.65B 420B P/E 2026 *
26.8x
P/E 2027 * 19.2x
Enterprise Value 2.17B 2.52B 2.04B 1.86B 3.5B 241B 3.51B 24.16B 9.43B 122B 9.46B 9.26B 403B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.51x
Free-Float
35.93%
Yield 2026 *
1.95%
Yield 2027 * 2.02%
1 day-0.87%
1 week-1.34%
Current month-7.03%
1 month-11.49%
3 months-11.64%
6 months-16.77%
Current year-19.63%
1 week 10.24
Extreme 10.24
10.54
1 month 10.24
Extreme 10.24
11.74
Current year 10.24
Extreme 10.24
13.98
1 year 10.24
Extreme 10.24
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.83
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 02/11/2022
Director of Finance/CFO 53 31/08/2025
Chief Tech/Sci/R&D Officer - 07/07/2021
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member - 01/01/2016
Chairman - 06/05/2022
Date Insider Type Main position Quantity % Market Cap.
6/23/23 A Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 A Buy 4,340 0.0024%
6/22/23 A Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%-1.34%-9.47%+9.50% 2.64B
-1.01%-7.24%+59.10%+110.24% 1,048B
+0.49%-1.41%+51.86%+62.18% 640B
-0.92%-3.68%+22.74%+73.10% 456B
-1.46%-4.50%+37.43%+38.41% 362B
-0.72%-2.89%+21.86%+36.79% 295B
-1.19%-2.21%+1.35%+10.79% 255B
-1.26%-1.83%+51.00%+68.10% 236B
+0.08%-1.78%-17.64%-54.29% 204B
-2.41%-0.77%+28.81%+88.20% 185B
Average -0.89%-0.65%+24.70%+44.30% 368.43B
Weighted average by Cap. -0.78%-1.92%+37.90%+64.49%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.15B 1.05B 1.98B 136B 1.99B 13.66B 5.33B 68.75B 5.35B 5.23B 228B 1.35B 1.57B 1.27B 1.16B 2.18B 150B 2.19B 15.04B 5.87B 75.69B 5.89B 5.76B 251B
Net income 82.4M 95.62M 77.26M 70.52M 133M 9.14B 133M 917M 358M 4.61B 359M 351M 15.3B 115M 134M 108M 98.76M 186M 12.8B 187M 1.28B 501M 6.46B 503M 492M 21.42B
Net Debt -93.03M -108M -87.23M -79.63M -150M -10.32B -150M -1.03B -404M -5.21B -405M -397M -17.27B -228M -264M -214M -195M -367M -25.27B -369M -2.53B -989M -12.76B -993M -971M -42.3B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
28/08/26 10.32 -0.77% 75,044
27/08/26 €10.40 -0.95% 131,088
26/08/26 €10.50 +1.16% 91,481
25/08/26 €10.38 +0.97% 115,434
24/08/26 €10.28 -1.72% 93,841
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.40EUR
Average target price
14.30EUR
Spread / Average Target
+37.50%

Quarterly revenue - Rate of surprise